Baird Medical to Participate in Roth's 3rd Annual Healthcare Opportunities Conference
GUANGZHOU, China , Oct. 9, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China which has recently expanded into the U.S. market following its receipt of US FDA 510(k) clearances, today announced that the Company will participate in the following investor conference.
Baird Medical's management plans to host one-on-one and small group meetings with institutional investors at the conference.
Roth's 3rd Annual Healthcare Opportunities Conference
Wednesday, October 9, 2024
Metropolitan Club, 1 E 60th Street, New York, NY, 10022
Baird Medical's participation in the event comes as the Company expands its footprint in the U.S. market following recent FDA clearance for its minimally invasive microwave ablation technology, which offers a promising alternative to thyroidectomy for patients with benign thyroid tumors. Currently, 150,000 thyroidectomies are performed in the U.S. annually.
What the stars mean:
★ Poor ★ ★ Promising ★★★ Good ★★★★ Very good ★★★★★ Exceptional
Tag:Related Contents
Latest News
Mobile Version